Clinical Trials Browser

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

NCT04223648 2021-11-22

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Phase EARLY_PHASE1 Withdrawn

Dermatologic

Melanoma

NCT04285749 2020-07-27

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

Phase EARLY_PHASE1 Withdrawn

Dermatologic

Melanoma

NCT03338777 2020-02-25

IGTM-101

Phase EARLY_PHASE1 Terminated

4 enrolled

Dermatologic

Melanoma

NCT02320305 2020-01-14

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Phase EARLY_PHASE1 Completed

23 enrolled

Dermatologic

Melanoma

NCT02316795 2019-09-24

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

Phase EARLY_PHASE1 Completed

20 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT01789827 2019-08-05

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

Phase EARLY_PHASE1 Completed

5 enrolled

Dermatologic

Melanoma

NCT00499733 2019-01-18

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Phase EARLY_PHASE1 Terminated

19 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Osteosarcoma, Tongue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Intraocular Lymphoma

NCT01568996 2018-01-09

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

Phase EARLY_PHASE1 Completed

17 enrolled

Dermatologic

Dysplastic Nevus Syndrome, Melanoma

NCT00871533 2017-08-04

Pilot Study of IFN α2b for Melanoma Patients

Phase EARLY_PHASE1 Terminated

50 enrolled

Dermatologic

Melanoma

NCT01425749 2016-04-04

Mel55

Phase EARLY_PHASE1 Completed

25 enrolled 12 charts

Dermatologic

Melanoma, Skin Diseases, Skin Neoplasms

NCT00470379 2014-10-31

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

Phase EARLY_PHASE1 Completed

30 enrolled

Dermatologic

Melanoma

NCT01620749 2012-06-15

MEL050

Phase EARLY_PHASE1 Unknown

12 enrolled

Dermatologic

Melanoma

NCT00580060 2011-06-10

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

Phase EARLY_PHASE1 Completed

20 enrolled

Dermatologic

Melanoma

Clinical Trials

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Mel 70

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Zr89 + PET Companion Trial

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

FAST-CR

MELRIV-1

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Tilmanocept

Mel61

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

MPAK

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

YSCH-01

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

IGTM-101

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

Pilot Study of IFN α2b for Melanoma Patients

Mel55

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

MEL050

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity